General Electric Company
Neuromodulation techniques

Last updated:

Abstract:

The subject matter of the present disclosure generally relates to techniques for following a treatment protocol having one or more treatment parameters to cause a targeted physiological outcome at a distal site, assessing an expression level of a gene in a region of interest after completing the treatment protocol, and modifying the one or more treatment parameters based on the expression level of the gene. The treatment protocol may include one or more ultrasound energy treatments to the region of interest.

Status:
Grant
Type:

Utility

Filling date:

26 Sep 2018

Issue date:

3 May 2022